Sibelius Natural Products, the British nutraceutical company, has announced the creation of Seneb Products Limited, a sister Canadian company established in association with a Vulpes-backed Cayman company. As part of the launch, Sibelius has exclusively licensed its Chronoscreen platform to Seneb for the investigation of the cannabis plant.
Peter Leyland, Sibelius CEO, explained: “Over the last 12 months Sibelius has been undertaking its largest ever investigation into the Cannabis plant using the Chronoscreen Platform, however, we have taken our investigative work in the UK as far as we can within the current regulatory framework. This opportunity with Seneb allows us to build on that great work.”
Read the full article on the Nutraceutical Business Review website here.
